NCT05627063
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05627063
Title A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Abbisko Therapeutics Co, Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89119 United States Details
Gabrail Cancer Center Research Canton Ohio 44718 United States Details
Chongqing University Cancer Hospital Chongqing Chongqing Municipality China Details
The First Affiliated Hospital of Henan University of Science & Technology Luoyang Henan China Details
The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China Details
Hubei Cancer Hospital Wuhan Hubei China Details
Hunan Central Hospital Changsha Hunan China Details
The Affiliated Hospital of Inner Mongolia Medical University Hohhot Inner Mongolia China Details
The First Affiliated Hospital of Nanchang University Nanchang Jiangxi China Details
Jilin Cancer Hospital Changchun Jilin China Details
The First Hospital of China Medical University Shenyang Liaoning China Details
Shanghai East Hospital Tongji University Shanghai Shanghai Municipality China Details
Shanxi Provincial Cancer Hospital Taiyuan Shanxi China Details
West China School of Medicine/West China Hospital of Sichuan University Chengdu Sichuan China Details
Mianyang Central Hospital Mianyang Sichuan China Details
Zhejiang University Cancer Hospital Hangzhou Zhejiang China Details
Fujian Cancer Hospital (Department of Hepatobiliary and Pancreatic Oncology /Phase I Ward) Fuzhou China Details
Harbin Medical University Cancer Hospital (Gastroenterology Department 2nd Ward) Haerbin China Details
Zhongshan Hospital of Fudan University (Hepatological Surgery Department) Shanghai China Details
Zhongshan Hospital of Fudan University (Medical Oncology Department) Shanghai China Details
Liaoning Cancer Hospital (Phase I Ward) Shenyang China Details
Yantai Yuhuangding Hospital (Department of Medical Oncology, 1) Yantai China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field